Dana Rochester is an Endocrinology/Metabolic physician affiliated with Albert Einstein College of Medicine. OpenAlex indexes 5 publications with 398 citations (h-index 3).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1010 Northern Blvd Ste 102
Great Neck, NY 110215306
Telephone
516-985-2196Provider last certified this registry record 10 Mar 2026.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year20254 payments
- Novo Nordisk IncProgram year20253 payments
- Alexion Pharmaceuticals, Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
68.2%RANK Ligand Inhibitor67.9%Denosumab100%Prolia1%Part D + Part B≥37 patientsBisphosphonates0.2%Risedronate Sodium100%Part D<11 patientsMetabolism & gastrointestinal
22.3%GLP-1 receptor agonist6.5%Ozempic58%Mounjaro32%Trulicity9%Part D<11 patientsBiguanide (metformin)5.9%Metformin Hcl Er71%Metformin Hcl29%Part D≥71 patients+ 7 more classes in this area
Hormonal (systemic)
7.3%l-Thyroxine6%Levothyroxine Sodium58%Synthroid35%Tirosint8%Part D<11 patientsThyroid Hormone Synthesis Inhibitor0.8%Methimazole100%Part D≥12 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Partial recovery of luteal function after bariatric surgery in obese women
Fertility and Sterility
2008 - Pulsatile Luteinizing Hormone Amplitude and Progesterone Metabolite Excretion Are Reduced in Obese Women
The Journal of Clinical Endocrinology & Metabolism
2007
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Lipton, MD
Albert Einstein College of Medicine
Marina Konopleva, MD, PhD
Albert Einstein College of Medicine
Solomon Moshe, MD
Albert Einstein College of Medicine
Shlomo Shinnar, MD, PhD
Albert Einstein College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”